IDEAS home Printed from https://ideas.repec.org/a/ids/ijmabs/v7y2026i2p138-162.html

Implementation of support vector regression and SARIMA for stock price prediction: Pfizer and AstraZeneca (2017-2025)

Author

Listed:
  • Nazhifa Capella Az'Zahra
  • Widiarti Putri Kinasih
  • Syifana Hilmi Muthmainnah
  • Maghfira Azmi Aqila
  • Lutfiyah Nur Azizah

Abstract

This study compares the seasonal autoregressive integrated moving average (SARIMA) and support vector regression (SVR) methods for forecasting the stock prices of Pfizer Inc. and AstraZeneca Plc from 2017 to 2025. Monthly closing prices were obtained from Yahoo Finance and analysed in R Studio. SARIMA successfully captured the seasonal behaviour of the data, whereas SVR was applied to model potential non-linear patterns. Model performance was evaluated using mean absolute percentage error (MAPE) and root mean square error (RMSE). The results show that SARIMA achieved higher accuracy, with MAPE values of 4.97% for AstraZeneca and 4.95% for Pfizer, outperforming the SVR model in both MAPE and RMSE metrics. Forecasts generated using the SARIMA (0,1,1)(1,0,0)[12] model indicate a steady increase in AstraZeneca's stock price throughout 2026. In contrast, Pfizer's stock price is projected to remain stable at approximately $31 per share. Overall, the SARIMA model proved to be more effective in this study for predicting pharmaceutical stock prices characterised by seasonal patterns and moderate volatility.

Suggested Citation

  • Nazhifa Capella Az'Zahra & Widiarti Putri Kinasih & Syifana Hilmi Muthmainnah & Maghfira Azmi Aqila & Lutfiyah Nur Azizah, 2026. "Implementation of support vector regression and SARIMA for stock price prediction: Pfizer and AstraZeneca (2017-2025)," International Journal of Markets and Business Systems, Inderscience Enterprises Ltd, vol. 7(2), pages 138-162.
  • Handle: RePEc:ids:ijmabs:v:7:y:2026:i:2:p:138-162
    as

    Download full text from publisher

    File URL: https://www.inderscience.com/link.php?id=155338
    Download Restriction: Access to full text is restricted to subscribers.
    ---><---

    As the access to this document is restricted, you may want to

    for a different version of it.

    More about this item

    Keywords

    ;
    ;
    ;
    ;
    ;
    ;
    ;
    ;
    ;
    ;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ids:ijmabs:v:7:y:2026:i:2:p:138-162. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sarah Parker (email available below). General contact details of provider: http://www.inderscience.com/browse/index.php?journalID=440 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.